Stellate Ganglion Block Versus Oral Medication in Treatment of Palmar Hyperhidrosis
NCT06731101 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46
Last updated 2026-02-06
Summary
The aim of the study is to compare between ganglion block versus combined oral anticholinergic and antidepressant drugs on treatment of palmar hyperhidrosis
Conditions
- Palmar Hyperhidrosis
Interventions
- DRUG
-
Bupivacaine + Lidocaine +dexamethasone
Sonar guided block of Stellate Ganglion By Bupivacaine + Lidocaine
- DRUG
-
Tryptizole + Librax
Tryptizole + Librax
Sponsors & Collaborators
-
Fayoum University
lead OTHER
Principal Investigators
-
Atef M Khalil, professor · Fayoum University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-01-15
- Primary Completion
- 2025-12-10
- Completion
- 2026-01-01
Countries
- Egypt
Study Locations
More Related Trials
-
Recovery of Diaphragmatic Function After Neuromuscular Blockade and Sugammadex
NCT01962298 ·Status: COMPLETED ·Phase: PHASE3
-
Electromyographic Activity of the Respiratory Muscles During Neostigmine or Sugammadex Enhanced Recovery After Neuromuscular Blockade
NCT02403063 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of Acthar in Subjects With ARDS
NCT02113735 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Clinical Trial to Assess Safety and Pharmacokinetics of Fosnetupitant 235 mg and Metabolites in Healthy Volunteers
NCT06840769 ·Status: TERMINATED ·Phase: PHASE1
-
Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn Surgery
NCT03513406 ·Status: COMPLETED ·Phase: PHASE3
-
Sugammadex vs. Neostigmine for Neuromuscular Blockade Reversal in Thoracic Surgical Patients
NCT03168308 ·Status: COMPLETED ·Phase: PHASE4
-
Residual Paralysis and Reversal With Routine Neostigmine Versus Half-dose Sugammadex and Routine Neostigmine
NCT05066035 ·Status: COMPLETED ·Phase: PHASE4
-
Thoracic Neuromodulation for Diabetic Gastroparesis
NCT05273788 ·Status: RECRUITING ·Phase: PHASE1
-
Staccato Zaleplon Single Dose Pharmacokinetics
NCT00620620 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
NCT01571297 ·Status: COMPLETED ·Phase: PHASE2
-
Release of Acetylcholine From the Ganglionated Plexus During the Thaw Phase of Cryoballon Pulmonary Vein Ablation (GP RESPONSE Study)
NCT03636100 ·Status: TERMINATED
-
Pharyngeal Electrical Stimulation for the Treatment of Post-extubation Dysphagia in Acute Stroke
NCT02470078 ·Status: COMPLETED ·Phase: NA
-
Reversal of Residual Neuromuscular Blockade at Train-of-four Ratio 0.3 With Sugammadex and Neostigmine
NCT03656614 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis
NCT04303195 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety, and Pharmacokinetics of Sugammadex for Reversal of Neuromuscular Blockade (NMB) in Pediatric Participants (MK-8616-089)
NCT03351608 ·Status: COMPLETED ·Phase: PHASE4
-
Sugammadex Dose Finding Under Two Years Old
NCT06575036 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Comparison of Sugammadex and Sugammadex-neostigmine Combination in the Antagonism of Moderate Neuromuscular Block
NCT05228223 ·Status: UNKNOWN ·Phase: NA
-
Residual Neuromuscular Blockade in Cardiac Surgery Patients
NCT03574337 ·Status: WITHDRAWN ·Phase: PHASE4
-
Sugammadex Versus Neostigmine in Pediatric Less Than Two Years Undergoing Cardiac Catheterization
NCT04258007 ·Status: COMPLETED ·Phase: NA
-
Thoracic Splanchnic Magnetic Neuromodulation Therapy (ThorS-MagNT) for Grade 3 Diabetic Gastroparesis: Pilot Study
NCT04706832 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study of Sugammadex Versus Usual Care on Incidence of Residual Blockade at Post Anesthesia Care Unit Admission (P07981)
NCT01479764 ·Status: COMPLETED ·Phase: PHASE3
-
Does Saline Injection Around Phrenic Nerve Reduce Incidence of Diaphragmatic Paresis Following Interscalene Block?
NCT02893228 ·Status: COMPLETED ·Phase: PHASE4
-
Diaphragm Function After Reversal of Rocuronium-induced Neuromuscular Blockade With Sugammadex or Neostigmine in Children
NCT05724550 ·Status: COMPLETED ·Phase: NA
-
Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome
NCT03649477 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Find the Highest Safe Dose of Soluble Guanylate Cyclase (sGC) Activator, BAY 1211163 Administered as Multiple Doses by Inhalation to Patients Who Cannot Breathe by Their Own and Suffer From a Type of Lung Failure That Causes Fluid to Build up in the Lungs Making Breathing Difficult (ARDS)
NCT04609943 ·Status: TERMINATED ·Phase: PHASE1